MARS is based on the application cell company's core patent "multi-physical configurable automatic separation" technology. Active acoustic microfluidic and magnetic separation techniques were used to isolate target cells from whole blood, singleton and bone marrow samples.

The installation sequence between functional modules can be freely combined to meet the different demands of customers and allow customization in the overall workflow and each individual processing step. At the same time, through the control of the core devices in the functional module, the target cells can be cleaned and concentrated.

MARS platform not only guarantees the value of specific cell integrity, high activity, and high purity, but also perfectly meets the downstream needs of cell applications, such as cell culture and drug resistance testing, flow analysis, gene mutation detection and gene sequencing, etc. It meets the broad clinical and clinical scientific research needs and realizes the transformation in the field of cell separation.